Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.77 USD | +16.80% | +22.25% | -12.84% |
May. 10 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
May. 09 | Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $16.6M, vs. Street Est of $16.3M | MT |
Business Summary
Number of employees: 227
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Soft-tissue Reconstruction Solutions
100.0
%
| 41 | 100.0 % | 58 | 100.0 % | +41.13% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 58 | 100.0 % | +41.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Antony Koblish
FOU | Founder | 58 | 12-04-16 |
Roberto Cuca
DFI | Director of Finance/CFO | 57 | 21-09-26 |
Marissa Conrad
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-23 |
Paul Talmo
CTO | Chief Tech/Sci/R&D Officer | 57 | 14-01-31 |
Investor Relations Contact | - | - | |
D. Taylor Ocasio
LAW | General Counsel | - | 22-04-17 |
Megan Smeykal
AUD | Comptroller/Controller/Auditor | 48 | 19-11-30 |
Bruce Freedman
PRN | Corporate Officer/Principal | - | 20-12-31 |
Peter Murphy
PRN | Corporate Officer/Principal | 52 | 20-01-28 |
Michael Leonard
PRN | Corporate Officer/Principal | - | 18-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Colleran
BRD | Director/Board Member | 66 | 20-04-19 |
Douglas Evans
CHM | Chairman | 59 | 20-04-19 |
Antony Koblish
FOU | Founder | 58 | 12-04-16 |
Vince Burgess
BRD | Director/Board Member | 59 | 14-05-31 |
Federica O’Brien
BRD | Director/Board Member | 66 | 19-11-12 |
Kurt Azarbarzin
BRD | Director/Board Member | 61 | 18-11-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,653,939 | 23,060,653 ( 93.54 %) | 0 | 93.54 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.84% | 142M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- TELA Stock
- Company TELA Bio, Inc.